Yao Y - Search Results

1

Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway.

Yao J, Xu T, Tian T, Fu X, Wang W, Li S, Shi T, Suo A, Ruan Z, Guo H, Yao Y. Yao J, et al. Among authors: yao y. Oncol Rep. 2016 Feb;35(2):1204-12. doi: 10.3892/or.2015.4437. Epub 2015 Nov 18. Oncol Rep. 2016. Retraction in: Oncol Rep. 2024 Jul;52(1):89. doi: 10.3892/or.2024.8748 PMID: 26718507 Retracted.

2

Polyelectrolyte-stabilized glucose biosensor based on woodceramics as electrode.

Qian JM, Suo AL, Yao Y, Jin ZH. Qian JM, et al. Among authors: yao y. Clin Biochem. 2004 Feb;37(2):155-61. doi: 10.1016/j.clinbiochem.2003.10.013. Clin Biochem. 2004. PMID: 14725949

3

Galactosylated poly(ethylene glycol)-b-poly (l-lactide-co-β-malic acid) block copolymer micelles for targeted drug delivery: preparation and in vitro characterization.

Suo A, Qian J, Yao Y, Zhang W. Suo A, et al. Among authors: yao y. Int J Nanomedicine. 2010 Nov 23;5:1029-38. doi: 10.2147/IJN.S14280. Int J Nanomedicine. 2010. PMID: 21170351 Free PMC article.

4

MicroRNA profiling of human gastric cancer.

Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni L, Zhang WG, Nan KJ, Song TS, Huang C. Yao Y, et al. Mol Med Rep. 2009 Nov-Dec;2(6):963-70. doi: 10.3892/mmr_00000199. Mol Med Rep. 2009. PMID: 21475928

5

Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2.

Suo A, Zhang M, Yao Y, Zhang L, Huang C, Nan K, Zhang W. Suo A, et al. Among authors: yao y. Med Oncol. 2012 Sep;29(3):1827-36. doi: 10.1007/s12032-011-0013-y. Epub 2011 Jul 7. Med Oncol. 2012. PMID: 21735146

6

CDK-associated Cullin 1 can promote cell proliferation and inhibit cisplatin-induced apoptosis in the AGS gastric cancer cell line.

Zheng Q, Zhao LY, Kong Y, Nan KJ, Yao Y, Liao ZJ. Zheng Q, et al. Among authors: yao y. World J Surg Oncol. 2013 Jan 13;11:5. doi: 10.1186/1477-7819-11-5. World J Surg Oncol. 2013. PMID: 23311997 Free PMC article.

7

Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer.

Hu T, Yao Y, Yu S, Guo H, Han L, Wang W, Tian T, Hao Y, Liu Z, Nan K, Wang S. Hu T, et al. Among authors: yao y. J Biomed Res. 2013 Jul;27(4):283-90. doi: 10.7555/JBR.27.20130069. Epub 2013 Jul 6. J Biomed Res. 2013. PMID: 23885267 Free PMC article.

8

Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.

Wang WJ, Yao Y, Jiang LL, Hu TH, Ma JQ, Liao ZJ, Yao JT, Li DF, Wang SH, Nan KJ. Wang WJ, et al. Among authors: yao y, yao jt. PLoS One. 2013 Oct 2;8(10):e76596. doi: 10.1371/journal.pone.0076596. eCollection 2013. PLoS One. 2013. PMID: 24098538 Free PMC article.

9

Increased LEF1 expression and decreased Notch2 expression are strong predictors of poor outcomes in colorectal cancer patients.

Wang WJ, Yao Y, Jiang LL, Hu TH, Ma JQ, Ruan ZP, Tian T, Guo H, Wang SH, Nan KJ. Wang WJ, et al. Among authors: yao y. Dis Markers. 2013;35(5):395-405. doi: 10.1155/2013/983981. Epub 2013 Sep 26. Dis Markers. 2013. PMID: 24223455 Free PMC article.

10

[CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications].

Hu T, Yao Y, Yu S, Guo H, Tian T, Han L, Wang W, Guo Q, Wang J, Nan K, Wang S. Hu T, et al. Among authors: yao y. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Feb;34(2):153-8. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24589587 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,545 results

Search Page

Filters